Close

×
Civil liability

Transvaginal Mesh

Blondin v. Coloplast Canada Corporation

The Superior Court of Quebec approved a settlement agreement which has been reached in the class action against Coloplast Canada Corporation concerning certain transvaginal mesh products for the treatment of stress urinary incontinence (SUI) and pelvic organ prolapse (POP).

THE CLAIM PERIOD IS NOW OVER.

What do you need to know?

The claim period under the settlement agreement approved by the Superior Court on November 29, 2023, is now over. You can no longer submit a claim.

A request has been made to the Court to authorize distribution of the settlement amount. The hearing is scheduled for September 18th, 2025.

An application has been made to the Court to authorize the distribution of the settlement amount to eligible members. The hearing will take place on September 18, 2025.

What does the Agreement approved by the Superior Court include?

The Agreement provides, among other things, for financial compensation for members who claim to have suffered damages in connection with the implantation of the following transvaginal mesh product: Aris, Exair, Minitape, Novasilk, Omnisure, Restorelle Direct Fix Anterior, Restorelle Direct Fix Posterior, Supris or T-Sling.

Settlement benefits for eligible claimants range from $2,000 to $55,000. You can consult the evaluation criteria that will guide the determination of compensation.

Coloplast will also pay to settle members’ valid claims of the Régie de l’assurance maladie du Québec, the costs of administering the settlement, and Class Counsel’s legal fees and disbursements.

The Agreement provides that all claimants’ files will be analyzed by an independent certified urologist who has been jointly selected by the Parties to the class action (the “Special Master”).

The Assessor will analyze the medical records received, which must be complete and unaltered, and will determine the amount of compensation to which the Claimant is entitled based on the damages suffered and according to the criteria set out in Schedule D of the Agreement.

The modified Agreement binds all parties and class members who have not opted out before the expiration of the opt-out period on August 4, 2023, even if you have not submitted a claim.

My claim is valid. When will I receive my compensation?

In accordance with the Settlement Agreement, the class counsel have submitted a report detailing all accepted claims to the Court in order to request the necessary authorization for the distribution of compensation.

The hearing is scheduled for September 18th, 2025.

As soon as the Court's distribution order becomes final, i.e., 31 days after the notice of judgment is issued, Coloplast will be able to send us the funds necessary for the payments. Subsequently, the payments will be able to be issued.

Check out our Frequently Asked Questions to find answers to your questions.